PhRMA: What’s ahead for biopharmaceuticals in 2013?
It’s human nature to look ahead to the New Year. What will 2013 hold for America’s biopharmaceutical research sector? Well, quite a bit. John Castellani We will join other stakeholders in the dialogue over the role of health care costs in our nation’s economic challenges. We will help implement and work to improve the health
